A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication

M. Arcos-Burgos, M. Jain, M. T. Acosta, S. Shively, H. Stanescu, D. Wallis, S. Domené, J. I. Vélez, J. D. Karkera, J. Balog, K. Berg, R. Kleta, W. A. Gahl, E. Roessler, R. Long, J. Lie, D. Pineda, A. C. Londõo, J. D. Palacio, A. ArbelaezF. Lopera, J. Elia, H. Hakonarson, S. Johansson, P. M. Knappskog, J. Haavik, M. Ribases, B. Cormand, M. Bayes, M. Casas, J. A. Ramos-Quiroga, A. Hervas, B. S. Maher, S. V. Faraone, C. Seitz, C. M. Freitag, H. Palmason, J. Meyer, M. Romanos, S. Walitza, U. Hemminger, A. Warnke, J. Romanos, T. Renner, C. Jacob, K. P. Lesch, J. Swanson, A. Vortmeyer, J. E. Bailey-Wilson, F. X. Castellanos, M. Muenke

Research output: Contribution to journalReview article

163 Scopus citations

Fingerprint Dive into the research topics of 'A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication'. Together they form a unique fingerprint.

Medicine & Life Sciences